Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects
Asıl Yazarlar: | Holman, R, Dinneen, S |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1999
|
Benzer Materyaller
-
The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
Yazar:: Tri Murti Andayani,, ve diğerleri
Baskı/Yayın Bilgisi: (2009-12-01) -
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999) -
Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
Yazar:: Wettergreen SA, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01) -
Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
Yazar:: P. Rosenbaum, ve diğerleri
Baskı/Yayın Bilgisi: (2002-08-01) -
Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
Yazar:: Hui Fang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)